Asia Pacific Automated Peritoneal Dialysis Market Size and Forecast (2021

Description

List of Tables

The Asia Pacific Automated Peritoneal Dialysis Market is projected to increase from US$ 301.2 Million in 2025 to US$ 445.0 Million by 2034. The market is expected to register a CAGR of 4.4% during the forecast period from 2026 to 2034.

Executive Summary and Asia Pacific Automated Peritoneal Dialysis Market Analysis

The Asia Pacific automated peritoneal dialysis market is witnessing continued expansion as the prevalence of kidney disease increases and healthcare systems across the region place greater emphasis on decentralized and patient-focused treatment models. According to the Global Burden of Disease Study 2023, Asia Pacific recorded one of the highest regional dialysis prevalences, at approximately 115 patients per 100,000 population in 2023. This substantial treatment burden indicates significant underlying demand for dialysis services, including peritoneal dialysis modalities such as APD.

The region also carries a considerable proportion of the global chronic kidney disease (CKD) burden. An estimated 434 million adults in Asia are living with CKD, including approximately 65.6 million individuals with advanced disease. This large patient population is generating increasing requirements for flexible and accessible renal replacement therapies, including automated peritoneal dialysis.

Healthcare authorities in several APAC countries are increasingly encouraging home-based dialysis options to improve treatment accessibility while reducing the strain on healthcare facilities. Various policymakers have introduced "PD first" and home-care-oriented initiatives that encourage earlier consideration of peritoneal dialysis and facilitate long-term management outside conventional dialysis centers. According to the International Society of Nephrology's Global Kidney Health Atlas, access to dialysis varies considerably across APAC countries; however, peritoneal dialysis is broadly recognized as an important modality for expanding renal care, particularly in areas where in-center dialysis infrastructure is constrained.

Strategic Insights

Asia Pacific Automated Peritoneal Dialysis Market Segmentation Analysis

By Product Type, the Asia Pacific Automated Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment accounted for the largest market share in 2025.

By End User, the Asia Pacific Automated Peritoneal Dialysis Market is divided into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment dominated the market in 2025.

Market Report Scope

Asia Pacific Automated Peritoneal Dialysis Market Outlook

Remote monitoring technologies are becoming increasingly important in the Automated Peritoneal Dialysis Market by allowing patients to transmit treatment information to healthcare professionals in near real time. These connected systems enhance clinical supervision while reducing the need for patients to make frequent visits to healthcare facilities. Research involving telemedicine and remote patient monitoring indicates that connected care can improve treatment adherence, facilitate earlier identification of complications, and potentially reduce hospitalizations, technique failures, and emergency interventions.

The COVID-19 pandemic significantly accelerated telehealth adoption, as temporary regulatory changes and expanded remote-care frameworks made virtual treatment management more practical. This acceleration supported the integration of remote monitoring technologies into home dialysis programs in several countries, including China. Modern APD systems equipped with Wi-Fi or cellular connectivity, cloud-based treatment management platforms, and integrated alarm functions provide clinicians with timely information regarding treatment parameters, dwell volumes, intraperitoneal pressures, and adherence. Such capabilities enable individualized treatment adjustments that would traditionally require direct clinical interaction.

Continued development of artificial intelligence-based predictive analytics could further enhance APD treatment personalization and enable earlier identification of potential adverse events. These innovations represent significant opportunities for APD manufacturers and healthcare providers. Digital technologies can also help address gaps in specialist access across rural and resource-constrained areas where nephrology expertise may be limited.

By integrating digital health capabilities directly into APD systems, healthcare stakeholders can potentially improve patient outcomes, strengthen product differentiation, and support broader adoption of automated peritoneal dialysis as a preferred home-based renal replacement therapy across diverse healthcare systems in the Asia Pacific region.

Asia Pacific Automated Peritoneal Dialysis Market Country Insights

By country, the Asia Pacific Automated Peritoneal Dialysis Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan held the largest market share in 2025.

According to the Japanese Society for Dialysis Therapy 2023 Annual Dialysis Data Report, more than 343,000 individuals in Japan were receiving dialysis at the end of 2023, including over 10,500 patients undergoing peritoneal dialysis. This represents a substantial patient population within a country characterized by a rapidly aging demographic. The combination of a large dialysis population, population aging, and a high prevalence of metabolic conditions such as diabetes continues to increase demand for convenient dialysis options that can support patient independence and quality of life.

Japanese healthcare policies are increasingly emphasizing home-based care and integrated approaches to chronic disease management, creating a favorable environment for automated dialysis technologies such as APD. These approaches can provide greater treatment flexibility while potentially improving resource utilization and making home dialysis more economically attractive.

Technological improvements have also increased the practicality of APD for elderly patients and their caregivers. Modern automated cyclers feature more intuitive interfaces, enhanced safety mechanisms, and remote support capabilities, simplifying treatment management and supporting better adherence. In addition, Japanese renal care practices are increasingly recognizing the potential benefits of home dialysis in managing comorbidities, supporting patient independence, and reducing the burden associated with repeated hospital visits and admissions.

Asia Pacific Automated Peritoneal Dialysis Market Company Profiles

Key companies operating in the Asia Pacific Automated Peritoneal Dialysis Market include Terumo Corp, Medtronic Plc, Asahi Kasei Corp, Baxter International Inc, Fresenius Medical Care AG & Co KGaA, B. Braun SE, Angiplast, Becton Dickinson and Co, Utah Medical Products Inc, and Poly Medicure Ltd.

These companies are pursuing several strategic initiatives, including geographic expansion, product development and innovation, and mergers and acquisitions. Through these strategies, market participants aim to introduce advanced products, address evolving healthcare and patient requirements, strengthen their competitive positions, and increase their respective market shares.

Product Code: TIPRE00043924

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Automated Peritoneal Dialysis Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. Asia Pacific Automated Peritoneal Dialysis Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Automated Peritoneal Dialysis Market - Asia Pacific Analysis

5.1 Asia Pacific Automated Peritoneal Dialysis Market Revenue (US$ Million), 2021 - 2034
5.2 Asia Pacific Automated Peritoneal Dialysis Market Revenue Forecast and Analysis

6. Asia Pacific Automated Peritoneal Dialysis Market Revenue Analysis - by Product Type

6.1 Asia Pacific Automated Peritoneal Dialysis Market Forecast and Analysis by Product Type
- 6.1.1 Peritoneal Dialysis Solution
  - 6.1.1.1 Overview
  - 6.1.1.2 Peritoneal Dialysis Solution: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.2 Peritoneal Dialysis Catheters
  - 6.1.2.1 Overview
  - 6.1.2.2 Peritoneal Dialysis Catheters: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.3 Peritoneal Dialysis Transfer Sets
  - 6.1.3.1 Overview
  - 6.1.3.2 Peritoneal Dialysis Transfer Sets: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.4 Others
  - 6.1.4.1 Overview
  - 6.1.4.2 Others: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

7. Asia Pacific Automated Peritoneal Dialysis Market Revenue Analysis - by End User

7.1 Asia Pacific Automated Peritoneal Dialysis Market Forecast and Analysis by End User
- 7.1.1 In-Center Dialysis Settings
  - 7.1.1.1 Overview
  - 7.1.1.2 In-Center Dialysis Settings: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.2 Home Care Settings
  - 7.1.2.1 Overview
  - 7.1.2.2 Home Care Settings: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

8. Asia Pacific Automated Peritoneal Dialysis Market - Country Analysis

8.1 Asia Pacific
- 8.1.1 Asia Pacific Automated Peritoneal Dialysis Market Forecast and Analysis - by Country
  - 8.1.1.1 China Market
    - 8.1.1.1.1 China: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.1.2 China: Asia Pacific Automated Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.1.2.1 Product Type
      - 8.1.1.1.2.2 End User
  - 8.1.1.2 Japan Market
    - 8.1.1.2.1 Japan: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.2.2 Japan: Asia Pacific Automated Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.2.2.1 Product Type
      - 8.1.1.2.2.2 End User
  - 8.1.1.3 India Market
    - 8.1.1.3.1 India: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.3.2 India: Asia Pacific Automated Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.3.2.1 Product Type
      - 8.1.1.3.2.2 End User
  - 8.1.1.4 Australia Market
    - 8.1.1.4.1 Australia: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.4.2 Australia: Asia Pacific Automated Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.4.2.1 Product Type
      - 8.1.1.4.2.2 End User
  - 8.1.1.5 South Korea Market
    - 8.1.1.5.1 South Korea: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.5.2 South Korea: Asia Pacific Automated Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.5.2.1 Product Type
      - 8.1.1.5.2.2 End User
  - 8.1.1.6 Rest of Asia Pacific Market
    - 8.1.1.6.1 Rest of Asia Pacific: Asia Pacific Automated Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.6.2 Rest of Asia Pacific: Asia Pacific Automated Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.6.2.1 Product Type
      - 8.1.1.6.2.2 End User

9 Automated Peritoneal Dialysis Market Industry Landscape

10 - Key Company Profiles

10.1 Terumo Corp
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Medtronic Plc
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Asahi Kasei Corp
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Baxter International Inc
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Fresenius Medical Care AG & Co KGaA
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B. Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Angiplast
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Becton Dickinson and Co
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Utah Medical Products Inc
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Poly Medicure Ltd
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 Glossary
11.4 Research Methodology and Approach
- 11.4.1 Secondary Research
- 11.4.2 Primary Research
- 11.4.3 Market Estimation Approach
  - 11.4.3.1 Supply Side Analysis
  - 11.4.3.2 Demand Side Analysis
- 11.4.4 Research Assumptions and Limitations
- 11.4.5 Currency Conversion
11.5 About The Insight Partners
11.6 Market Intelligence Cloud